Immunocine
Cancer Center
Personalized cancer immunotherapy built around the biology of your own tumor.
After my brain tumor was removed, I spent a lot of time researching what I wanted to do next. I looked at the standard options, but I also wanted to understand what else was being studied and used around the world. One area I became particularly interested in was immunotherapy.
That research eventually led me to Immunocine Cancer Center in Cancún, Mexico. In February 2025, I traveled there to receive personalized dendritic cell therapy using material from the tumor that had been removed during my surgery.
Dendritic cell therapy sounds complicated, but the basic concept is fairly straightforward.
What Are Dendritic Cells?
Dendritic cells are a normal part of the immune system. One of their jobs is to collect information about potential threats and present that information to other immune cells, including T cells.
This matters in cancer because cancer cells come from our own cells. They have become abnormal, but recognizing those abnormal cells and mounting an effective immune response against them is complicated.
Dendritic cell therapy is an area of immunotherapy research that attempts to use this existing function of the immune system. Dendritic cells can be exposed to tumor-associated material and then used with the goal of helping the immune system recognize relevant targets.
In my case, Immunocine used material from my actual tumor as part of that process.
Why the Treatment Is Personalized
Cancer can vary significantly from one person to another. Two people can receive the same diagnosis and still have important biological differences between their tumors. This was one of the things that interested me most about Immunocine.
Because tissue from my tumor had been preserved following surgery, it could be used as part of developing my personalized therapy. Immunocine also collected immune cells from my blood, which were used in the process of preparing my dendritic cells.
Put simply, they were able to use information from my own tumor as part of a treatment designed specifically for me. There is considerably more science involved in the process, but that personalization was one of the primary reasons I decided to pursue it.
What You Should Do
I've done many things, so I don't attribute my outcome to any single treatment, nor do I believe that something I chose is automatically appropriate for another person.
I share Immunocine because it was part of my own journey and because many people simply don't know that personalized approaches like dendritic cell therapy exist. If you're facing cancer, I believe it's worth becoming educated about your options, asking questions, reviewing the research, and discussing those options with qualified healthcare professionals who understand your individual case.
If you'd like to learn more about Immunocine, their approach to dendritic cell therapy, and how the process works, click below.
